# Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

> **NCT01764841** · PHASE3 · COMPLETED · sponsor: **Bayer** · enrollment: 416 (actual)

## Conditions studied

- Bronchiectasis

## Interventions

- **DRUG:** Ciprofloxacin DPI (BAYQ3939)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01764841
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05-02
- **Primary completion:** 2016-03-09
- **Final completion:** 2016-03-09
- **Target enrollment:** 416 (ACTUAL)
- **Last updated:** 2018-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01764841

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01764841, "Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT01764841. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*